# Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)

> **NCT00314366** · PHASE1 · COMPLETED · sponsor: **Texas Heart Institute** · enrollment: 21 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **BIOLOGICAL:** Stem Cell Therapy
- **OTHER:** Control (plasma)

## Key facts

- **NCT ID:** NCT00314366
- **Lead sponsor:** Texas Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2009-08
- **Final completion:** 2023-08-24
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314366, "Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00314366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*